Search Results

Site Search

New test distinguishes between prion disease and other causes of rapidly progressive dementia - Insights

Performed on cerebrospinal fluid, Mayo Clinic’s RT-QuIC prion test can distinguish prion disease from other types of rapidly progressive dementias to enhance patient care.

Driving change in women's health testing through pioneering research and novel testing strategies - Insights

New diagnostic tests specifically for conditions that predominantly or only affect women, such as autoimmune diseases and gynecological cancers, are empowering female patients and their physicians to make informed decisions.

GeoBioMed: How geologic rock formations inform novel treatments for kidney stones - Part I - Insights

A collaborative study between Mayo Clinic and the University of Illinois debunked the previous consensus about how kidney stones grow.

Dengue Virus: A Diagnostic Testing Update - Insights

In this month’s “Hot Topic,” Elitza Theel, Ph.D., talks about Mayo Clinic Laboratories’ serologic and molecular testing for the identification of infection with dengue virus. Dengue virus poses a significant public health threat worldwide....

Genetics - Mayo Clinic Laboratories

Our genetic testing was developed by experienced geneticists, genetic counselors, laboratory scientists, and bioinformaticians. We focus on providing easy to understand answers, interpreted by those same individuals who have an intimate...

quality-compliance.pdf

@2021 Mayo Foundation for Medical Education and Research Framework for Quality Updated: 12/13/2024 Mayo Clinic Laboratories measure quality not simply by accreditation and licensure, but also by how efficiently esoteric laboratory...

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) - Insights

In this month's "Hot Topic," Eoin Flanagan, M.B., B.Ch., reviews the recent diagnostic criteria for Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD).

Cytogenetic Testing for Pediatric Patients With Hematologic Malignancies - Insights

In this month's "Hot Topic," Patricia Greipp, D.O., discusses fluorescence in situ hybridization, or FISH testing, particularly related to pediatric patients with hematologic malignancies.

Diagnostic Testing Algorithms for Celiac Disease - Insights

In this month's "Hot Topic," Melissa Snyder, Ph.D., co-director of the antibody immunology laboratory at Mayo Clinic, discusses celiac disease and the role of diagnostic testing algorithms.

IMPACTS Team Continues to Combat Life-Threatening Arthropod-Borne Infections in Belize - Insights

Now in its second year of a five-year initiative to better understand and detect arboviruses in Belize, the IMPACTS (Integrated Mayo Clinic Program for Arbovirus Community health education Training and Surveillance) project has expanded its...